Alternatives to Rejuvenate Bio

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing epigenetic reprogramming drugs for age restoration.

Scalable, one-time curative in-vivo gene editing therapies.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology company developing genetic therapies for rare disorders.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Engineering scalable gene therapies for broader patient populations.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Developing oral small molecule medicines for immunological and chronic diseases.

Advancing next-generation mRNA medicines.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

AI-enabled technology for cell biology research and biopharma development.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing disease-responsive advanced therapies through programmable gene control technology.

Venture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

A de-extinction biotechnology company aiming to revive extinct species.

Developing an automated platform for liquid biopsy sample preparation.

Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.

AI safety and research company building reliable, interpretable, and steerable AI systems.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A global leader in clinical pharmacology and bioanalytical sciences.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Developing novel immunotherapies and diagnostics for cancer.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

Developing gene editing therapies to lower cholesterol.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI-powered knowledge discovery for life sciences.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.